Search Results 51-60 of 16875 for Liposome

1. Liposomal Bupivacaine Single-Injection Interscalene Block vs. Continuous Interscalene Block for Primary Total Shoulder Arthroplasty - Mayo Clinic

   The purpose of this study is to assess analgesia effectiveness between liposomal bupivacaine single injection interscalene blockade vs. continuous interscalene ...

2. A Study to Evaluate Wound Infiltration with Liposomal Bupivacaine in Laparotomy for Gynecological Malignancy - Mayo Clinic

   ... (liposomal bupivacaine) injection for pain management after abdominal surgery for gynecological cancer. Participation eligibility. Participant eligibility ...

3. A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection - Mayo Clinic

   A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...

4. Loco-Regional Liposomal Bupivacaine Injection in Lower Extremity Revascularization - Mayo Clinic

   The purpose of this study is to compare loco-regional liposomal bupivacaine injection versus normal saline (placebo control group) to assess possible reduction ...

5. Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty - Mayo Clinic

   The purpose of this study is to determine if peripheral nerve block with liposomal bupivacaine in combination with standard bupivacaine will prolong the ...

6. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

   Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast ...

7. Postoperative Analgesia after Breast Reduction Surgery Comparing Liposomal Bupivacaine versus 0.25% Bupivacaine Hydrochloride - Mayo Clinic

   The purpose of this study is to compare liposomal bupivacaine and 0.25% Bupivacaine Hydrochloride as local infiltration. Participation eligibility.

8. A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial to Demonstrate the Efficacy and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI Investigational eFlow® Device plus Standard of Care versus Standard of Care Alone in the Treatment of Chronic Lung Allograft Syndrome / Bronchiolitis Obliterans Syndrome in Patients post Double Lung Transplantation (BOSTON-2) - Mayo Clinic

   A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial to Demonstrate the Efficacy and Safety of Liposomal Cyclosporine A (L-CsA) ...

9. Mumps Virus Vaccine, Live (Subcutaneous Route) Before Using - Mayo Clinic

   Cytarabine Liposome; Dacarbazine; Dasatinib; Daunorubicin; Daunorubicin Citrate Liposome; Daunorubicin Liposome; Deflazacort; Docetaxel; Doxorubicin; Epirubicin ...

10. A Study for Women who have Platinum Resistant Ovarian Cancer to Evaluate EC145 Combined with Pegylated Liposomal Doxorubicin, Compared to Pegylated Liposomal Doxorubicin Alone - Mayo Clinic

    ... Liposomal Doxorubicin, Compared to Pegylated Liposomal Doxorubicin Alone ... liposomal doxorubicin (EC145+PLD) with those who receive PLD alone.